Transparency Market Research in its new report titled, “Sanger Sequencing Service Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the Sanger sequencing service market. The TMR report anticipates that the growing demand for pharmacogenomics in drug discovery & development will drive the Sanger sequencing service market during the forecast period i.e, 2018-2026. The other factors anticipated to drive the market for Sanger sequencing during the forecast period include declining prices of sequencing, technological advancements, increasing demand for affordable genotyping services, rising incidence and awareness on genetic diseases and personalized medicine, and high use of genetic analysis in animals and plants, says the report.
Technological advancements in the field of organ transplantations, favorable investments, funds, and grants by government bodies across the globe, increasing public-private investments, growing applications of genotyping, and rising number of soft tissue, solid organ, and stem cell transplantations are anticipated to drive the Sanger sequencing service market in the next few years. In terms of application, the Sanger sequencing service market is divided into shotgun sequencing, targeted gene sequencing, and others. Based on laboratory, the market is bifurcated into web labs and dry labs. In terms of research, the Sanger sequencing service market can be segregated into in-house and outsourced. Based on end-user, the market is categorized into pharmaceutical & biotechnology companies, academic & research institutes, and others.
On a regional standpoint, the global Sanger sequencing service market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these, North America is estimated to account for the largest share of the global Sanger sequencing service market in 2017, followed by Europe and Asia Pacific. Key emerging markets such as China, India, and Brazil are expected to offer significant growth opportunities to stakeholders associated with the market. Rise in collaborations, partnerships, and agreements among market players, surge in government funding for translational research, improving healthcare infrastructure are likely to increase demand of Sanger sequencing services in the Asia Pacific region. Increase in competition in mature markets and relatively less-stringent regulations and data requirements as compared to developed nations are other key factors that makes Asia Pacific an attractive region for stakeholders, anticipates the report.
Some of the major players operating in the global sanger sequencing service market are profiled in this report and these include Eurofins Scinetific, Genscript Biotech, Biocompare, Inc., GENEWIZ, Source BioScience plc, Nucleics Pty. Ltd., First BASE Laboratories Sdn Bhd, MRC Protein Phosphorylation and Ubiquitylation Unit, LGC Ltd., and BaseClear.
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453